Endovascular Today

What Is Your Strategy for Determining When a Superficial Reflux Pattern Requires Treatment?

Experts discuss how they interpret reflux patterns, symptom severity, and anatomic factors to guide decisions on when ...
TCTMD

Covidien Announces Five-Year Results from the ClosureFast™ Long-Term European Multi-Center Study in Patients with Lower Limb Venous Disease

Study Demonstrates Long-Term Durability of the ClosureFast™ Radiofrequency Ablation System for Treatment of Chronic Venous Insufficiency MANSFIELD, Mass.-- Covidien, a leading global provider of ...
Nasdaq

New Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024

IRVINE, CA / ACCESSWIRE / April 16, 2024 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous disease, today ...
Endovascular Today

A Private Practice Physician’s Experience Treating Chronic Venous Insufficiency

Robert A. Edwards, DO Medical Director, Center for Vein Care Horizon Diagnostics Columbus, Georgia redwards@hdllc.org ...
The New England Journal of Medicine

Chronic Venous Insufficiency and Varicose Veins

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...
Nasdaq

Positive Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical’s VenoValve(R) Pivotal Trial to be Presented Today at the VENOUS2024 American ...

97% of VenoValve Study Patients Showing Clinical Improvement at Six Months (as Measured by the Revised Venous Clinical Severity Score (rVCSS)) 74% of the Study Patients Showing Clinical Meaningful ...